(NEW YORK)Dynavax Technologies Corp. and Merck & Co. said Tuesday that their application to test the experimental hepatitis B vaccine Heplisav on humans is still on hold because of safety wo...READ MORE
(NEW YORK)Shares of Dynavax Technologies Corp. fell Thursday as the biotechnology company responded to a Food and Drug Administration request for more information on a halted study of the de...READ MORE
Among the stock activity stories for Thursday, Sept. 18, from AP Financial News: CHICAGO (AP)--Shares of Pier 1 Imports Inc. climbed Thursday even after the home decor chain posted...READ MORE
(BERKELEY, Calif.)Shares of Dynavax Technologies Corp. plummeted Friday after the drug developer said it is ending development of its ragweed allergy drug Tolamba after it failed a midstage trial.READ MORE
(NEW YORK)Shares of General Electric Co. rose in premarket trading Friday after the company confirmed it plans to sell or spin-off its century-old appliance business.READ MORE